학술논문
Lysophosphatidic acid receptor 1 antagonist (EPGN2154) causes regression of NASH in preclinical NASH models.
Document Type
Article
Author
Source
Hepatology Communications; Dec2023, Vol. 7 Issue 12, p1-13, 13p
Subject
Language
ISSN
2471254X